M&T Bank’s Sanofi SNY Stock Holding History

M&T Bank’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3	Closed	-$1K	–	1689
2017 Q1	$1K	Buy	+3	New	+$127	﹤0.01%	1655
2016 Q3	–	Sell	-3	Closed	-$1K	–	1767
2016 Q2	$1K	Buy	+3	New	+$123	﹤0.01%	1687

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

M&T Bank's SNY Position: Q2 2026 in Review

M&T Bank reduced its Sanofi (SNY) stake by 0.83% in Q2 2026, selling an estimated $171K and leaving 455,290 shares worth $19.4M. The position accounts for 0.06% of the portfolio, ranked #219.

M&T Bank first reported a position in SNY in Q2 2013 and has held it in 53 quarters since. The position peaked at $25M in Q1 2025. 717 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

M&T Bank held 455,290 shares of Sanofi worth $19.4M as of Q2 2026.
M&T Bank sold 3,828 Sanofi shares in Q2 2026, an estimated $171K.
Sanofi made up 0.06% of M&T Bank's portfolio in Q2 2026, its #219 holding.
M&T Bank first reported a position in Sanofi in Q2 2013 and has held it in 53 quarters since.
M&T Bank's Sanofi position peaked at $25M in Q1 2025.
717 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.